Apellis Pharmaceuticals, Inc.【APLS】業績推移・財務諸表

（単位：千ドル）	3Q17	4Q17	1Q18	2Q18	3Q18	4Q18	1Q19	2Q19	3Q19	4Q19	1Q20	2Q20	3Q20	4Q20	1Q21	2Q21	3Q21	4Q21	1Q22	2Q22	3Q22	4Q22	1Q23	2Q23	3Q23	4Q23	1Q24	2Q24	3Q24	4Q24	1Q25	2Q25	3Q25	4Q25
売上高	-	-	-	-	-	-	-	-	-	-	-	-	646	250,000	-	600	5,650	60,290	14,381	16,322	22,056	22,663	44,846	94,969	110,399	146,377	172,325	199,685	196,830	212,528	166,797	178,494	458,578	199,913
売上成長率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-			-											45.2	-3.2	-10.6	133.0	-5.9
研究開発費	9,517	-	17,402	27,537	29,539	30,805	40,479	50,698	51,319	78,471	69,282	87,094	93,207	50,337	84,012	95,943	87,733	78,181	90,945	101,661	95,207	99,423	110,027	95,658	79,421	69,282	84,701	77,947	88,569	76,354	86,420	67,015	68,186	74,233
販売管理費	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	129,505	128,081	121,984	121,482	129,345	131,139	142,678	147,103
営業費用	-	-	-	-	-	-	-	-	-	-	-	-	130,198	119,879	-	194,910	133,645	149,694	143,379	164,946	174,994	186,716	219,929	215,410	247,479	230,895	234,415	229,128	244,110	238,692	250,125	211,780	235,395	251,055
営業利益	-11,590	-17,569	-21,439	-33,486	-35,805	-37,197	-48,651	-63,477	-69,948	-105,941	-98,786	-115,508	-129,552	130,120	-124,591	-194,287	-127,995	-89,404	-128,998	-148,624	-152,938	-164,053	-175,083	-120,441	-137,080	-84,518	-62,090	-29,443	-47,280	-26,164	-83,328	-33,286	223,183	-51,142
営業利益率 (%)	-	-	-	-	-	-	-	-	-	-	-	-			-															-12.3	-50.0	-18.6	48.7	-25.6
経常（税引前）利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-137,727	-155,491	-190,823	-167,462	-177,496	-121,843	-140,004	-87,153	-66,253	-37,543	-56,853	-36,067	-91,884	-41,685	216,317	-58,638
経常（税引前）利益率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-957.7	-952.6	-865.2	-738.9	-395.8	-128.3	-126.8	-59.5	-38.4	-18.8	-28.9	-17.0	-55.1	-23.4	47.2	-29.3
法人税等合計	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,200	500	400	-1,431	300	200	233	1,432	200	100	600	262	300	500	600	322
実効税率（％）	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-												-0.7	-0.3	-1.2	0.3	-0.5
純利益	-11,574	-18,256	-21,737	-33,335	-35,973	-36,460	-50,575	-71,091	-69,825	-113,218	-168,822	-118,617	-135,700	78,265	-183,659	-219,191	-195,571	-147,933	-138,935	-155,977	-191,269	-165,991	-177,778	-122,037	-140,237	-88,576	-66,423	-37,657	-57,445	-36,353	-92,225	-42,151	215,715	-58,951
純利益率（％）	-	-	-	-	-	-	-	-	-	-	-	-			-															-17.1	-55.3	-23.6	47.0	-29.5
一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.46	-1.75	-1.5	-1.56	-1.02	-1.17	-0.72	-0.54	-0.3	-0.46	-0.29	-0.74	-0.33	1.71	-0.47
希薄化後一株あたり利益	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1.46	-1.75	-1.5	-1.56	-1.02	-1.17	-0.72	-0.54	-0.3	-0.46	-0.29	-0.74	-0.33	1.67	-0.45

Apellis Pharmaceuticals, Inc.【APLS】 業績推移・財務諸表

Apellis Pharmaceuticals, Inc.【APLS】業績推移・財務諸表